Category: Cannabis Info

07/09/2025 – 08:30 AM

Ten-Year Legacy Brand Joins THCT Portfolio, Expanding National Craft Cannabis Footprint and Female-Founded Leadership

MEDFORD, Ore., July 09, 2025 (GLOBE NEWSWIRE) — THC Therapeutics, Inc. (“THCT” or the “Company”), (OTC: THCT), a company focused on the legal and regulated cannabis industry, is proud to announce the acquisition of all issued and outstanding membership interests of STHoldings Group LLC, the parent company of iconic Eugene, Oregon cannabis brand SugarTop Buddery, in an all-share transaction valued at approximately $3 million. The deal was satisfied entirely through the issuance of newly created Series D Preferred stock.

This marks THCT’s second strategic acquisition in its ongoing roll-up strategy, following its June 2025 acquisition of The Headquarters Group. With this transaction, THCT expands its operations in Oregon and gains ownership of a widely respected and culturally significant craft cannabis company with deep roots in the Pacific Northwest.

Founded in 2015, SugarTop Buddery has become synonymous with community-driven, music-inspired cannabis and is celebrating its 10-year anniversary with this milestone. The brand, built by co-founder and CEO Anna Kaplan, has long been recognized for its commitment to artistry, equity, and sustainability, receiving consistent praise from cannabis publications and retailers for its emphasis on craft, culture, and the empowerment of women in cannabis.

“This transaction is an opportunity not only for myself, but for the brand I have spent the last decade building to have the future growth it deserves,” said Anna Kaplan, CEO of SugarTop Buddery. “Having fought our way through 10 years of volatility in a mature market like Oregon, our move under the THCT umbrella will provide the capital, infrastructure, and greater resources for SugarTop Buddery and our family of brands to truly emerge on a national and international stage. I am very much looking forward to engaging with new markets on the East Coast and bringing the best of what craft cannabis can be to the nation.”

STHoldings Group LLC includes not only SugarTop Buddery’s primary operating company STB Enterprises LLC, but also STIP, an intellectual property company holding the brand’s trademarks and media assets, and STH Enterprises LLC, its hemp-focused subsidiary. Collectively, the entities generated ~$2.1 million in revenue in 2024, with peak performance reaching ~ $4.3 million in 2022.

“The acquisition of STHoldings Group adds another powerful and resilient brand to the THCT portfolio,” said Scott Cox, CEO of THC Therapeutics, Inc. “Anna Kaplan’s leadership and the legacy of SugarTop Buddery are exactly the kind of values-driven, operationally resilient, and culturally iconic assets that fit our strategy. As one of the few female-founded and female-led cannabis companies to scale through Oregon’s challenging market conditions, SugarTop Buddery brings authenticity, a loyal customer base, and a unique brand DNA that cannot be replicated.”

SugarTop Buddery is known for its music and artist collaborations, stylish pre-rolls, and emphasis on social equity and women in cannabis—frequently cited in media outlets such as MJBizDaily, MJBrandInsights, and Willamette Week, for its innovative branding and leadership in Oregon’s competitive cannabis sector.

“Anna’s voice and strategic brand-building instincts will play a central role in shaping THCT’s consumer strategy across our entire portfolio,” added Mr. Cox. “This acquisition is not just about the assets—it’s about the people, the purpose, and the power of culture in shaping long-term brand value.”

With this acquisition, THCT deepens its operational presence in Oregon and strengthens its foundation for a bi-coastal, vertically integrated national cannabis platform. The Company remains focused on acquiring proven operators and market-leading brands in cultivation, manufacturing, and distribution—brands that resonate with consumers and reflect cannabis culture’s highest values.

About SugarTop Buddery

Founded in 2015, SugarTop Buddery is a family-owned and operated vertically licensed cannabis company based in Eugene, Oregon. Over the past decade, the company has successfully maintained every license type available in Oregon’s regulated market, including cultivation, processing, wholesale, and retail.

SugarTop Buddery has become a household name in the Pacific Northwest, building a reputation rooted in integrity, innovation, and artistry. Known for its commitment to no-till, living soil craft cultivation, SugarTop was also Oregon’s first branded pre-roll company, and the first to introduce a 10-pack of pre-rolls to the state. It continues to be a market leader and innovator in the pre-roll category with a focus on quality, consistency, and creative collaborations. In addition to the brand’s beloved products, SugarTop Buddery offers contract manufacturing services and full-service statewide distribution. With its deep roots and broad reach, SugarTop Buddery participates in every segment of Oregon’s recreational cannabis supply chain.

Widely celebrated for its retro-inspired branding, music and artist collaborations, and woman-led leadership, SugarTop Buddery exemplifies the values of community-driven cannabis. The company is recognized not only as a pioneer in product innovation but as a torchbearer for cultural integrity in an evolving industry.

Learn more at www.sugartopbuddery.com.

About THC Therapeutics, Inc.
THC Therapeutics, Inc. (OTC: THCT) is a U.S. public company focused on acquiring and operating a portfolio of synergistic assets and companies within the legal cannabis industry. With a bi-coastal focus, our vertically integrated business model positions our portfolio for rapid growth in cultivation, manufacturing, and distribution. THCT’s “hands-on and ancillary” strategy enables it to capitalize on the fastest-growing segments of the cannabis industry, while creating long-term value for shareholders. Learn more at www.thct.life.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1955. These forward-looking statements include, without limitation, THCT’s expectations regarding the receipt of requisite financing, if at all, the performance of the assets, our portfolio, execution of THCT’s business plan and the expectations regarding THCT’s ability to raise capital and maximize stockholder value. Words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions are intended to identify such forward-looking statements.

Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside of THCT’s control and are difficult to predict.

Factors that may cause actual future events to differ materially from the expected results, include, but are not limited to: (i) THCT’s ability to execute our acquisition and disposition strategy and grow and manage growth profitability and retain our key employees; (ii) the ability to maintain the listing of our common stock on the OTC Markets; (iii) the risk that the Company is not able to maintain and enhance our brand and reputation in our marketplace, adversely affecting THCT’s business, financial condition and results of operations; (iv) the risk that periods of rapid growth and expansion could place a significant strain on resources, including our employee base, which could negatively impact operating results; (v) the risk that THCT may never achieve or sustain profitability; (vi) the risk that THCT may need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; and (vii) other risks and uncertainties indicated from time to time in our Annual Report on Form 10-K for the fiscal year ended April 30, 2024 (the “Annual Report”) filed with the Securities and Exchange Commission (“SEC”) on August 13, 2024.

The foregoing list of factors is not exhaustive. There may be additional risks that THCT does not know or that currently believes to be immaterial that could also cause results to differ from those contained in any forward-looking statements. Recipients should carefully consider such factors and the other risks and uncertainties described in the “Risk Factors” section of the Annual Report and the periodic reports and other documents filed or to be filed by THCT from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.

Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and THCT assumes no obligation to, and does not intend to, update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. THCT does not give any assurance that we will achieve our expectations.

Contact for THC Therapeutics, Inc. (OTC: THCT)

info@thct.life
www.thct.life

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/de9ea1c7-4267-4d12-9c8d-d68dfe51cf6a

KALAMAZOO, MI (WKZO AM/FM) – After some in the industry predicted 2025 could be a watershed year for legalized marijuana retailers in Michigan, a cannabis company has announced it is closing its 20 Michigan dispensaries and all four of its cultivation and processing facilities in the state.

TerrAscend Corp. announced that it would lay off 236 employees, closing all operations in the state. That includes Gage stores in Kalamazoo, Lansing, and Battle Creek, and the Cookies dispensary in Kalamazoo.

The company is also closing two cultivation and processing facilities in Harrison Township and one each in Bay City and Warren.

Jason Wild, the company’s executive chairman said in a statement, “Michigan is an extremely difficult market and we have come to the realization that our resources can be better utilized in our other markets.” “

The company will continue to operate in New Jersey, Maryland, Pennsylvania, and Ohio.

In the early hours of Tuesday, July 8, police officers in Sala Al Jadida successfully thwarted a drug smuggling operation, seizing 4.9 tons of cannabis resin.

According to a security source, the operation took place on the outskirts of Sala Al Jadida and led to the interception of a utility vehicle carrying 122 bundles of cannabis resin, with a total weight of 4 tons and 924 kilograms, intended for international trafficking. Authorities also seized an inflatable boat and a marine engine, while the vehicle’s driver managed to flee the scene before police arrived.

A specialized judicial police unit has opened a criminal investigation under the supervision of the relevant public prosecutor to determine the full circumstances, identify all parties involved, and uncover the broader motives behind the operation.

This seizure reflects the ongoing efforts of the General Directorate of National Security (DGSN) to combat international drug and psychotropic substance trafficking.

“Once the Ministry’s regulations on retail control are enforced within this year, it will mean that these shops must have a doctor on-site, essentially transforming them from retail establishments into healthcare facilities. However, in the interim, until enforcement begins, they will use the prescription for controlled herbs instead, and the professionals performing this task must be trained by the Department,” Dr Somruek explained.

Following the training, the first batch of 1,000 Thai traditional medicine doctors will be ready on July 16.

Currently, discussions are ongoing to create an IT system allowing retail outlets to access information regarding cannabis bud usage and prescription management. 

On July 9, the Department will test the system with 50 patients who received service and use the controlled herb prescription (cannabis).

As for how the public will know where doctors who can issue prescriptions are located, a system is being developed, but it is contingent on finalizing the list of trained professionals.

The department is also working on integrating telemedicine systems, which will be available for both hospitals and clinics, though the system is still under development.

SURFSIDE BEACH, S.C. (WPDE) — The Surfside Beach Town Council has taken a significant step toward regulating vape and cannabis shops within town limits.

After a roughly eight-month moratorium that halted the approval of new business licenses for these shops, the council has initially approved new regulations after a unanimous vote Tuesday on first reading.

Councilman Harry Kohlmann expressed optimism about resolving the issue, saying, “Hopefully we can put this issue to bed.”

The new ordinance introduces a thousand-foot restriction, limiting where cannabis or CBD shops can operate.

Councilman Bill Kinken questioned the practicality of the restriction, asking, “With a thousand-foot restriction, where can you put one in Surfside?”

The ordinance was prompted by a police raid last September on a cannabis dispensary allegedly selling THC products exceeding state limits.

The planning commission, now chaired by Dusty McCracken, has drafted rules prohibiting these shops from being within a thousand feet of each other and near schools, residences, or churches.

READ MORE: Surfside Beach closes in on new regulations for tobacco and vape shop businesses

The town attorney, Jarrett Bouchette, did say parts of the ordinance may be difficult to enforce when it comes to penalizing shop ownership, but overall, he endorsed the proposed ordinance.

“When you look at it in totality, I think it comports with what the Supreme Court has laid out,” Bouchette said.

The lapse of the moratorium revealed that the four existing shops in town were improperly allowed to sell cannabis products. Until the ordinance is fully approved, no new shops can open.

“We’re actually opening up to allow these shops, our Uses Chart currently bans them. It doesn’t allow any of them to be in town. Within this ordinance here we’re allowing them to be in town and do that,” McCracken noted.

The council’s approval of the ordinance marks the first step in establishing precise rules and accountability measures for shopkeepers. A second and final vote is scheduled for later this month.

Legal medicinal cannabis clinics have changed everything. No longer do patients have to search for the symbols of illegal drug supply. Access is now simple, credible and in broad daylight.

But alarmingly, two-thirds of New Zealanders still believe there’s a stigma associated with accessing medicinal cannabis (based on research commissioned by One Plus One).

It’s a stigma that means that Kiwi patients have another unwelcome issue to deal with on top of their need for the product in the first place. Working with the Cannabis Clinic, New Zealand’s leading, independent clinics for medicinal cannabis, ABEL has created a campaign designed to take this on.

The first anti-stigma campaign for medicinal cannabis in New Zealand, the work uses the most enduring symbol of the illegal cannabis trade — trainers flung over a power line.

Flipping this visual on its head to highlight the conversation that needs to be had — it’s medicinal, not criminal. With a suite of OOH visuals and social films imbued with the individuality and humanity of real patients, it was launched with a hard-to-ignore specially built billboard on Newton Road courtesy of Bootleg Designs.

Founder, Dr Waseem Alzaher, said, “The goal was to stop people in their tracks and to challenge the shame and stigma surrounding medicinal cannabis that unfairly impacts our patients everyday, despite being legal. We wanted to make a bold statement on behalf of the category that challenges the current conversation. ABEL, One Plus One and the team they built around them were the perfect partners to do it with.”

The OOH, shot by Troy Goodall, is designed to embed itself within the fabric of the urban landscape — with their provocative nature and subtle twist becoming a powerful conversation starter.

The cinematic social films then go a level deeper, bringing to life the personal stories of Cannabis Clinic patients and their journey towards overcoming the stigma they feel everyday. Written and Directed by Supernormal’s Alice Cogin, are a raw and timely wake-up call to a country struggling to look beyond cannabis’ past, instead of openly accepting its medicinal future.

ABEL creative partner Simon Fowler said, “We are incredibly proud to have been entrusted with such a brave and important message by our team at Cannabis Clinic. At ABEL we believe in the power of creativity to drive real change. We hope this work challenges us all to rethink our response to medicinal cannabis patients and realise they’re everyday people like you and me.”

There’s no shortage of vape cartridges in New York’s booming legal cannabis market—but if you’re looking for something that actually delivers on flavor, potency, and value, it’s time to pay attention to Silly Nice. This Black- and Veteran-Owned craft cannabis brand is flipping the script with high-THC vape carts made from 100% cannabis-derived terpenes, all for just $40 before tax.

Launched in March 2024, Silly Nice has quickly built a reputation for small-batch excellence, clean ingredient sourcing, and transparency. In just over a year, the brand has landed in 135+ licensed dispensaries and been named one of New York’s Top 150 Cannabis Brands out of a field of more than 500. Their growth hasn’t been fueled by flashy ads or influencer gimmicks—it’s the product quality that’s speaking loudest.

What Makes These Vapes Different?

Let’s start with what’s inside. Most cartridges on the market cut corners with synthetic flavorings, distillate blends, or terpene “reconstructions.” Not Silly Nice. Each 1G 510 Thread Cartridge is crafted with 100% cannabis-derived terpenes—meaning everything you taste and smell is from the plant, not a lab.

Then there’s the cannabinoid content. Both their Runtz and Northern Lights vape carts test in the low-to-mid 80s for THC potency (81.96% and 84.66%, respectively), but the real magic lies in the total cannabinoid percentages—88.36% for Runtz and 91.21% for Northern Lights. These are full-spectrum carts that go beyond THC, preserving cannabinoids like CBG, CBC, CBN, THCa, and THCv to create a richer, more balanced experience.

This isn’t just about getting high—it’s about getting high smarter, with effects that are both potent and nuanced. That’s the entourage effect in action, and Silly Nice leans into it hard.

Silly Nice Runtz Vape Cartridge: Flavorful, Balanced, Potent

The Runtz cart is a hybrid that’s perfect for just about any time of day. You’ll notice it immediately—sweet, fruity, and smooth. That flavor? It’s real. No fake candy flavoring here, just genuine cannabis terpenes drawn directly from the Runtz strain.

Backed by a cannabinoid breakdown that delivers both clarity and relaxation, this vape is equally effective whether you’re powering through creative work or settling in for a casual evening. Beta-Caryophyllene and Limonene are the lead terpenes, supporting stress relief while subtly boosting your mood.

Whether you’re a flavor chaser, a terp nerd, or someone who just wants a reliable cart that actually feels good in the body, the Runtz cart delivers.

Northern Lights Cartridge: For Those Who Want to Fully Unwind

On the other end of the spectrum, the Silly Nice Northern Lights cart is your ideal nighttime companion. This indica-dominant vape leans into its strain legacy with an earthy, slightly sweet profile and a relaxing, full-bodied effect. With a THC content of 84.66% and total cannabinoids over 91%, this isn’t just potent—it’s deeply satisfying.

The terpene breakdown complements the mood perfectly. Beta-Caryophyllene adds a warm, soothing sensation, while Limonene subtly lifts the spirit without energizing. This cart is perfect for ending your day, easing tension, or settling into a long weekend without being overwhelmed.

Full-Spectrum: Why It Matters

Full-spectrum cannabis products retain the widest range of cannabinoids and terpenes. That means you’re not just consuming THC—you’re experiencing the plant’s full profile. Silly Nice doesn’t cut corners. Their vapes preserve compounds like CBD, CBG, CBN, THCv, and more, all contributing to what users often describe as a more effective and “complete” high.

The entourage effect is more than just a buzzword—it’s how nature designed cannabis to work. And Silly Nice is one of the few brands making sure it stays intact in their vape carts.

Transparency Is Standard, Not Optional

Every batch of Silly Nice vapes is lab-tested and comes with a Certificate of Analysis (COA) for consumers who care about what they’re putting into their bodies. These COAs confirm cannabinoid content, terpene presence, and the absence of harmful contaminants.

You won’t have to chase down a QR code or wonder where your vape came from—Silly Nice makes the process simple, honest, and upfront.

Small Batch, Big Movement

Silly Nice doesn’t try to be everything to everyone. Instead, they’ve built a focused, loyal community of fans who appreciate quality weed made with care. The brand is Black-owned, Veteran-owned, and proudly local to New York. Their growth is intentional, their quality is consistent, and their drops move fast.

They’ve proven you don’t need corporate dollars or celebrity endorsements to rise—just great product and word-of-mouth from people who actually use it.

Where to Find Silly Nice Vapes

These $40 vape carts are now available at licensed dispensaries across New York. From Manhattan to Syracuse, Albany to Buffalo, Silly Nice products are stocked at some of the most respected shops in the state.

Don’t expect them to stay in stock for long. These are limited, freshly made batches that tend to fly off the shelf. To find the nearest location, visit sillynice.com/locations.

Final Pull

When you consider the high potency, full-spectrum profile, real cannabis terpenes, lab testing, and accessible price point, it’s hard to beat what Silly Nice is doing with its 1G 510 vape cartridges. Whether you’re more into the balanced hybrid vibe of Runtz or prefer the evening ease of Northern Lights, there’s a cart here for you.

These aren’t just vapes—they’re thoughtful, effective wellness tools made by a brand that actually gives a damn about what goes into your body.

If you’re shopping for legal weed in New York this weekend, don’t sleep on these carts. They’re flying off shelves—and for good reason.

And remember: if you have a great visit at a dispensary, ALWAYS TIP YOUR BUDTENDER.